80 related articles for article (PubMed ID: 9381306)
1. [Autotransplant of CD34+ stem cells from peripheral blood separated using an immunomagnetic method in cancer of the breast].
Correa MA; González A; Garzón S; Rubio V; Hermosín L; Campos R; Jean-Paul E; Guzmán JL; Romero R; Gutiérrez R; Couto C; León A
Sangre (Barc); 1997 Apr; 42 Suppl 1():57-60. PubMed ID: 9381306
[No Abstract] [Full Text] [Related]
2. Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapy.
Mohr M; Hilgenfeld E; Fietz T; Hoppe B; Koenigsmann M; Hoffmann M; Knauf WU; Cassens U; Sibrowski W; Kienast J; Thiel E; Berdel WE
Clin Cancer Res; 1999 May; 5(5):1035-40. PubMed ID: 10353736
[TBL] [Abstract][Full Text] [Related]
3. Variables associated with the platelet count 6 weeks after autologous peripheral blood progenitor cell transplantation.
Bolwell B; Goormastic M; Andresen S; Koo A; Wise K; Overmoyer B; Pohlman B; Kalaycio M
Bone Marrow Transplant; 1998 Sep; 22(6):547-51. PubMed ID: 9758341
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cells.
Witzens-Harig M; Heilmann C; Hensel M; Kornacker M; Benner A; Haas R; Fruehauf S; Ho AD
Stem Cells; 2007 Jan; 25(1):228-35. PubMed ID: 17204607
[TBL] [Abstract][Full Text] [Related]
5. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
Benedetti G; Patoia L; Giglietti A; Alessio M; Pelicci P; Grignani F
Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956
[TBL] [Abstract][Full Text] [Related]
6. Transplantation of CD34+ peripheral blood cells selected using a fully automated immunomagnetic system in patients with high-risk breast cancer: results of a prospective randomized multicenter clinical trial.
Yanovich S; Mitsky P; Cornetta K; Maziarz RT; Rosenfeld C; Krause DS; Lotz JP; Bitran JD; Williams S; Preti R; Somlo G; Burtness B; Mills B
Bone Marrow Transplant; 2000 Jun; 25(11):1165-74. PubMed ID: 10849529
[TBL] [Abstract][Full Text] [Related]
7. [Effect of growth factor on the phenotype of subpopulations and on the kinetics of CD34+ cells in the peripheral blood and in grafts of peripheral stem cells in patients with non-Hodgkin's lymphoma indicated for autologous peripheral blood stem cell transplantation].
Klabusay M; Lysák D; Hrabcáková V; Navrátil M; Coupek P; Mayer J
Cas Lek Cesk; 2008; 147(6):319-24. PubMed ID: 18724529
[TBL] [Abstract][Full Text] [Related]
8. Mobilisation of peripheral blood stem cells with IVE and G-CSF improves CD34+ cell yields and engraftment in patients with non-Hodgkin's lymphomas and Hodgkin's disease.
McQuaker I; Haynes A; Stainer C; Byrne J; Russell N
Bone Marrow Transplant; 1999 Oct; 24(7):715-22. PubMed ID: 10516673
[TBL] [Abstract][Full Text] [Related]
9. CD34+ cell adhesion molecule profiles differ between patients mobilized with granulocyte-colony-stimulating factor alone and chemotherapy followed by granulocyte-colony-stimulating factor.
Ford CD; Greenwood J; Anderson J; Snow G; Petersen FB
Transfusion; 2006 Feb; 46(2):193-8. PubMed ID: 16441594
[TBL] [Abstract][Full Text] [Related]
10. [Characteristics of blood cells during peripheral blood stem cell mobilization following chemotherapy in patients with non-Hodgkin's lymphoma].
Okada Y; Ando M; Kato T; Taji H; Kagami Y; Ogura M; Morishima Y
Rinsho Ketsueki; 2000 Feb; 41(2):91-6. PubMed ID: 10723236
[TBL] [Abstract][Full Text] [Related]
11. Mobilization and transplantation of peripheral blood stem cells.
Shadduck RK; Zeigler ZR; Andrews DF; Gilmore GL; Lister J
Stem Cells; 1998; 16 Suppl 1():145-58. PubMed ID: 11012157
[TBL] [Abstract][Full Text] [Related]
12. Isolation of CD34+ cells from blood stem cell components using the Baxter Isolex system.
Rowley SD; Loken M; Radich J; Kunkle LA; Mills BJ; Gooley T; Holmberg L; McSweeney P; Beach K; MacLeod B; Appelbaum F; Bensinger WI
Bone Marrow Transplant; 1998 Jun; 21(12):1253-62. PubMed ID: 9674860
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing hematopoietic recovery after autologous blood stem cell transplantation in patients with acute myeloblastic leukemia and with non-myeloid malignancies.
Carral A; de la Rubia J; Martín G; Martínez J; Sanz G; Jarque I; Sempere A; Soler MA; Marty ML; Sanz MA
Bone Marrow Transplant; 2002 May; 29(10):825-32. PubMed ID: 12058232
[TBL] [Abstract][Full Text] [Related]
14. 4-Hydroperoxycyclophosphamide purged autologous bone marrow transplantation of relapsed, responding non-Hodgkin's lymphoma with granulocyte colony stimulating factor support results in reliable hematopoietic recovery.
Biggs D; Stadtmauer E; Mangan P; Edelstein M; Powlis W; Buzby G; Magee D; Sachs B; Silberstein L
Prog Clin Biol Res; 1994; 389():9-15. PubMed ID: 7535466
[No Abstract] [Full Text] [Related]
15. [Effect of immunomagnetic selection in purging autologous peripheral blood progenitor cell of breast cancer patients].
Han X; Shi Y; Zhang W
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):203-6. PubMed ID: 11953162
[TBL] [Abstract][Full Text] [Related]
16. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience.
Leong CF; Habsah A; Teh HS; Goh KY; Fadilah SA; Cheong SK
Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409
[TBL] [Abstract][Full Text] [Related]
17. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
Kasow KA; Sims-Poston L; Eldridge P; Hale GA
Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
[TBL] [Abstract][Full Text] [Related]
18. Cell adhesion molecule expression on CD34+ cells in grafts and time to myeloid and platelet recovery after autologous stem cell transplantation.
Watanabe T; Dave B; Heimann DG; Jackson JD; Kessinger A; Talmadge JE
Exp Hematol; 1998 Jan; 26(1):10-8. PubMed ID: 9430509
[TBL] [Abstract][Full Text] [Related]
19. Autografting with peripheral blood CD34-positive cells following high-dose chemotherapy against breast cancer.
Okumura A; Tokuda Y; Ohta M; Suzuki Y; Saito Y; Kuge S; Kubota M; Makuuchi H; Tajima T; Nakamura Y; Hotta T
Tokai J Exp Clin Med; 1999 Dec; 24(4-6):141-6. PubMed ID: 10819494
[TBL] [Abstract][Full Text] [Related]
20. Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.
Wang S; Nademanee A; Qian D; Dagis A; Park HS; Fridey J; Smith E; Snyder D; Somlo G; Stein A; Rosenthal J; Falk P; Kogut N; Palmer J; Gaal K; Kim Y; Bhatia R; Yuan S; Kay C; Weiss L; Forman S
Transfusion; 2007 Dec; 47(12):2207-16. PubMed ID: 17714420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
